Bausch + Lomb
Yesterday, eye health company Bausch + Lomb (B+L) sent a letter written by B+L's U.S. Surgical General Manager and Senior Vice President Andrew Chan to US ophthalmologists, showcasing the company's progress and continued commitment to the eye care community.
In the letter, Chang details the US growth of the B+L Surgical business of more than 40 percent. He also mentions B+L has grown its sales and clinical support team by 20 percent and invested more than $20 million in resident education, educational and charitable grants.
For the future, Chang states B+L plans to continue providing innovations in cataract, retina and refractive surgery, and continue its business development and R&D efforts.
Click here to read the full letter.